Drugs / HIV-1 Peptide Immunogen, Multivalent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00000846 | — | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV-1 Peptide Immunogen, Multivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000846 ↗ |
| Modality | Vaccine | “2 different HIV-1 peptide candidate vaccines” NCT00000846 ↗ |
| Route | Intramuscular | “UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection” NCT00000846 ↗ |